Reduction of dysfunction in angioplasty procedures

A composition for reducing dysfunction in angioplasty procedures comprises a selected amount of a carrier and a prostaglandin compound carried in a specified amount. The carrier does not alter the prostaglandin compound and releases the prostaglandin compound at a rate sufficient to dilate blood ves...

Full description

Saved in:
Bibliographic Details
Main Author SHELL, WILLIAM ELSON
Format Patent
LanguageEnglish
French
German
Published 08.04.1987
Edition4
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A composition for reducing dysfunction in angioplasty procedures comprises a selected amount of a carrier and a prostaglandin compound carried in a specified amount. The carrier does not alter the prostaglandin compound and releases the prostaglandin compound at a rate sufficient to dilate blood vessels to thereby produce the required efficacy. A prepackaged combination of components provides for the complete administration of the protaglandin compound before, during and after the anaioplasty procedure.
Bibliography:Application Number: EP19860113836